Abiopharma

🔍 Devereaux Terah L (Executive)

Company: REGENCY CENTERS CORP (REG)

Report Date: 2026-06-12

Detailed Transactions and Holdings:

• Sold 1,240 shares of Common Stock at $80.135 per share (Direct)
  Date: 2026-06-12 | Code: S | equity_swap_involved: false | shares_owned_after: 17,990.00 | transaction_form_type: 4
• Sold 620 shares of Common Stock (Direct)
  Date: 2026-06-12 | Code: G | equity_swap_involved: false | shares_owned_after: 17,370.00 | transaction_form_type: 5 | Footnotes: F1

Footnotes:

• F1: The shares were disposed as a bona fide gift. No consideration was received by the Reporting Person in connection with this transaction.